Clinical Trials
14 trialsNCT03682029 2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA Unknown
NCT04429191 2021-06-11
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Jasper Therapeutics, Inc.
Phase 1 Unknown
NCT02124174 2021-04-26
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
Phase 2 Unknown
NCT04517175 2020-08-18
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
Maastricht University
Unknown
NCT03836690 2019-10-25
ToTem
University College, London
Phase 1 Unknown
NCT04060485 2019-08-19
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
National Taiwan University Hospital
Unknown
NCT02007811 2014-03-26
B-cell therapy
University of Erlangen-Nürnberg Medical School
Phase 1/2 Unknown
NCT00084695 2014-01-10
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003827 2013-12-04
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003602 2013-09-20
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00596999 2012-04-10
HPDSC
Celgene
Unknown
NCT00002926 2010-05-27
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00315419 2010-04-21
Identifying Characteristics of Bone Marrow Failure Syndromes
Office of Rare Diseases (ORD)
Unknown
NCT00043134 2010-04-13
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 3 Unknown